Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
The Queen's representative in Canada says he "heartily" encourages the romance.
Shadow Chancellor John McDonnell will say Britain is in the grip of a "debt crisis" as he promises reforms to help people pay back loans.
The 58-year-old man was stabbed in the neck as he approached the Altrincham Islamic Centre in Manchester.